Richard Keld

586 total citations
18 papers, 218 citations indexed

About

Richard Keld is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Richard Keld has authored 18 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Gastroenterology. Recurrent topics in Richard Keld's work include Esophageal Cancer Research and Treatment (6 papers), Esophageal and GI Pathology (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Richard Keld is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Esophageal and GI Pathology (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Richard Keld collaborates with scholars based in United Kingdom, Ireland and Australia. Richard Keld's co-authors include Yeng Ang, Baoqiang Guo, Paul Downey, Christian Gulmann, Robert P. Willert, Abhishek Sharma, Mahesh Bhalme, Simon Campbell, Andrew D. Sharrocks and Andrew D Sharrocks and has published in prestigious journals such as Gastroenterology, Gut and British Journal of Cancer.

In The Last Decade

Richard Keld

16 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Keld United Kingdom 7 78 67 64 57 53 18 218
Danielle C. Costigan United States 9 48 0.6× 52 0.8× 20 0.3× 33 0.6× 83 1.6× 14 276
Stefano Taraglio Italy 10 126 1.6× 30 0.4× 20 0.3× 56 1.0× 65 1.2× 24 263
Golda Shelley‐Fraser United Kingdom 6 55 0.7× 32 0.5× 34 0.5× 26 0.5× 122 2.3× 7 208
Satoshi Okada Japan 7 76 1.0× 78 1.2× 28 0.4× 28 0.5× 43 0.8× 16 245
Anna Bozzola Italy 8 130 1.7× 45 0.7× 25 0.4× 51 0.9× 10 0.2× 22 235
Antonio Magnano Italy 9 102 1.3× 156 2.3× 49 0.8× 108 1.9× 32 0.6× 19 361
Alona Meir Israel 8 155 2.0× 49 0.7× 67 1.0× 13 0.2× 55 1.0× 14 294
Asad Haider United States 6 33 0.4× 75 1.1× 26 0.4× 21 0.4× 45 0.8× 13 287
C. K. Park South Korea 8 156 2.0× 87 1.3× 25 0.4× 38 0.7× 165 3.1× 14 400
Kidist Yimam United States 9 137 1.8× 38 0.6× 18 0.3× 141 2.5× 108 2.0× 21 312

Countries citing papers authored by Richard Keld

Since Specialization
Citations

This map shows the geographic impact of Richard Keld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Keld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Keld more than expected).

Fields of papers citing papers by Richard Keld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Keld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Keld. The network helps show where Richard Keld may publish in the future.

Co-authorship network of co-authors of Richard Keld

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Keld. A scholar is included among the top collaborators of Richard Keld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Keld. Richard Keld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Britton, James, Neeraj Prasad, Richard Keld, et al.. (2024). Development and validation of a novel Barrett's oesophagus patient reported outcome measure (B-PROM). EClinicalMedicine. 72. 102606–102606. 2 indexed citations
2.
3.
Britton, James, Calvin Heal, Richard Keld, et al.. (2023). Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy. BMJ Open Gastroenterology. 10(1). e001091–e001091. 2 indexed citations
4.
5.
Britton, James, et al.. (2018). Dedicated service improves the accuracy of Barrett’s oesophagus surveillance: a prospective comparative cohort study. Frontline Gastroenterology. 10(2). 128–134. 9 indexed citations
6.
Britton, James, Richard Keld, Neeraj Prasad, et al.. (2017). Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life. ˜The œLancet. Gastroenterology & hepatology. 3(1). 57–65. 19 indexed citations
7.
8.
Singh, Satnam, et al.. (2014). PTH-068 Reducing The Outpatient Burden Of 2 Week Wait Upper Gi Referrals. Gut. 63(Suppl 1). A239.1–A239. 1 indexed citations
9.
Keld, Richard. (2014). Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population. World Journal of Gastroenterology. 20(34). 12212–12212. 7 indexed citations
10.
Mooney, Peter D., et al.. (2014). Su1449 Adherence to Duodenal Biopsy Guidelines Increases the Detection of Coeliac Disease: A Multicentre UK Study. Gastroenterology. 146(5). S–472. 1 indexed citations
11.
12.
Bhalme, Mahesh, Abhishek Sharma, Richard Keld, Robert P. Willert, & Simon Campbell. (2013). Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?. European Journal of Gastroenterology & Hepatology. 25(5). 543–549. 64 indexed citations
13.
Bhalme, Mahesh, et al.. (2012). PTU-107 Weight adjusted anti-TNF therapy favours obese patients with Crohn's disease. Gut. 61(Suppl 2). A228.1–A228. 2 indexed citations
14.
Keld, Richard, et al.. (2011). Amyloidosis: an EUS view. Gastrointestinal Endoscopy. 75(1). 218–220. 4 indexed citations
15.
Keld, Richard, et al.. (2011). Pathogenesis, investigation and dietary and medical management of gastroparesis. Journal of Human Nutrition and Dietetics. 24(5). 421–430. 10 indexed citations
16.
Keld, Richard, Baoqiang Guo, Paul Downey, et al.. (2011). PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma. British Journal of Cancer. 105(1). 124–130. 45 indexed citations
17.
Keld, Richard, Baoqiang Guo, Paul Downey, et al.. (2010). The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Molecular Cancer. 9(1). 313–313. 49 indexed citations
18.
Keld, Richard, Baoqiang Guo, Paul Downey, et al.. (2010). OC-051 Erk MAP kinase signalling and PEA3 are synergistic in predicting adversity in gastric adenocarcinomas. A21.1–A21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle C. Costigan Breakdown of academic impact, for papers by Stefano Taraglio Breakdown of academic impact, for papers by Golda Shelley‐Fraser Breakdown of academic impact, for papers by Satoshi Okada Breakdown of academic impact, for papers by Anna Bozzola Breakdown of academic impact, for papers by Antonio Magnano Breakdown of academic impact, for papers by Alona Meir Breakdown of academic impact, for papers by Asad Haider Breakdown of academic impact, for papers by C. K. Park Breakdown of academic impact, for papers by Kidist Yimam
Rankless by CCL
2026